RIGEL PHARMACEUTICALS, INC. Company Profile
RIGEL PHARMACEUTICALS, INC. as SEC EDGAR records it: incorporation, addresses, industry, fiscal year end, filer category and former names.
- Current registered country: Value Delaware, United States.
- Country of operation (business address): Value United States.
- Business address: Value 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, California, 94080, United States.
- Mailing address: Value 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, California, 94080, United States.
| Measure | Value |
|---|---|
| Current registered country | Delaware, United States SEC EDGAR state of incorporation DE |
| Country of operation (business address) | United States |
| Business address | 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, California, 94080, United States |
| Mailing address | 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, California, 94080, United States |
| Industry (SIC) | 2834 Pharmaceutical Preparations |
| Fiscal year end | 12-31 |
| Filer category | Accelerated filer |
| Listed stock (Section 12(b)) | Common Stock, par value $0.001 per share · RIGL · NASDAQ 10-Q filed 2026-08-04 cover |
| Shell company | No 10-Q filed 2026-08-04 cover |
| Smaller reporting company | No 10-Q filed 2026-08-04 cover |
| Emerging growth company | No 10-Q filed 2026-08-04 cover |
| Current in its reporting | Yes 10-Q filed 2026-08-04 cover |
| Well-known seasoned issuer | No 10-K filed 2026-03-03 cover |
| Voluntary filer | No 10-K filed 2026-03-03 cover |
| Former names | RIGEL PHARMACEUTICALS INC (2000-10-03 to 2026-09-03) |
| First EDGAR filing | 2000-02-04 (S-1) |
| SEC CIK | 1034842 |
| EIN | 943248524 |
| Phone | 650-624-1100 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |